Publications by authors named "Amy Shurtleff"

Claim this Profile
T
The power of microbial life for the transformation towards a sustainable planet: key messages from the 2024 IUMS Congress in Florence, the city of the Renaissance.
Luisa Borgianni, Gianluigi Cardinali, Cristina Cassetti, Duccio Cavalieri, Carlotta De Filippo, Amy Shurtleff

Microlife· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of Immunogenicity and Protection of rVSV∆G-ZEBOV-GP Vaccine in a Nonhuman Primate EBOV Challenge Model.
Sandra L Bixler, Amy C Shurtleff, Melek M E Sunay, Kenneth Liu, Ziqiang Chen

Viruses· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
rVSVΔG-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model.
Amy C Shurtleff, John C Trefry, Sheri Dubey, Melek M E Sunay, Kenneth Liu

Viruses· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease.
Nancy A Niemuth, Dawn Fallacara, Cheryl A Triplett, Sanjay M Tamrakar, Alisha Rajbhandari, Amy C Shurtleff

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens.
Solomon Abebe Yimer, Birgitte Boonstra Booij, Gwen Tobert, Andrew Hebbeler, Paul Oloo, Amy Shurtleff

BMJ Glob Health· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates.
Bronwyn M Gunn, Ryan P McNamara, Lianna Wood, Sabian Taylor, Anush Devadhasan, Amy Shurtleff

Cell Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical countermeasures against henipaviruses: a review and public health perspective.
Raúl Gómez Román, Nadia Tornieporth, Neil George Cherian, Amy C Shurtleff, Maïna L'Azou Jackson

Lancet Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities for Refinement of Non-Human Primate Vaccine Studies.
Mark J Prescott, Carolyn Clark, William E Dowling, Amy C Shurtleff

Vaccines (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent successes in therapeutics for Ebola virus disease: no time for complacency.
Patrick L Iversen, Christopher D Kane, Xiankun Zeng, Rekha G Panchal, Travis K Warren, Amy C Shurtleff

Lancet Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test.
Krishnamurthy Konduru, Amy C Shurtleff, Sina Bavari, Gerardo Kaplan

J Virol Methods· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
Krishnamurthy Konduru, Amy C Shurtleff, Steven B Bradfute, Siham Nakamura, Sina Bavari

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo.
Kelly L Warfield, Travis K Warren, Xiangguo Qiu, Jay Wells, Chad E Mire, Amy C Shurtleff

Antiviral Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Filovirus Plaque Assay for Use in Preclinical Studies.
Amy C Shurtleff, Holly A Bloomfield, Shannon Mort, Steven A Orr, Brian Audet

Viruses· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
Travis K Warren, Robert Jordan, Michael K Lo, Adrian S Ray, Richard L Mackman, Amy C Shurtleff

Nature· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models for ebolavirus countermeasures discovery: what defines a useful model?
Amy C Shurtleff, Sina Bavari

Expert Opin Drug Discov· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Ebola Virus Inhibitors for Drug Repurposing.
Peter B Madrid, Rekha G Panchal, Travis K Warren, Amy C Shurtleff, Aaron N Endsley

ACS Infect Dis· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-symptomatic diagnosis and treatment of filovirus diseases.
Amy C Shurtleff, Chris A Whitehouse, Michael D Ward, Lisa H Cazares, Sina Bavari

Front Microbiol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
Karen Martins, John H Carra, Christopher L Cooper, Steven A Kwilas, Camenzind G Robinson, Amy C Shurtleff

Viral Immunol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSPA5 is an essential host factor for Ebola virus infection.
St Patrick Reid, Amy C Shurtleff, Julie A Costantino, Sarah R Tritsch, Cary Retterer

Antiviral Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1.
Audrey Page, Valentina A Volchkova, Saint Patrick Reid, Mathieu Mateo, Audrey Bagnaud-Baule, Amy C Shurtleff

Cell Rep· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents.
Peter B Madrid, Sidharth Chopra, Ian D Manger, Lynne Gilfillan, Tiffany R Keepers, Amy C Shurtleff

PLoS One· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation.
Kathleen A Cashman, Kate E Broderick, Eric R Wilkinson, Carl I Shaia, Todd M Bell, Amy C Shurtleff

Vaccines (Basel)· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of the filovirus plaque assay for use in preclinical studies.
Amy C Shurtleff, Julia E Biggins, Ashley E Keeney, Elizabeth E Zumbrun, Holly A Bloomfield

Viruses· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment.
Amy C Shurtleff, Nicole Garza, Matthew Lackemeyer, Ricardo Carrion, Anthony Griffiths

Viruses· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.
Amy C Shurtleff, Tam L Nguyen, David A Kingery, Sina Bavari

Expert Opin Drug Discov· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis